Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Double-blind Placebo-controlled Study Investigating the Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With SARS-CoV-2 Infection

NCT04488575 is registered in ClinicalTrials.gov with Evelo Biosciences, Inc. as lead sponsor.

NCT NCT04488575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04488575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Double-blind Placebo-controlled Study Investigating the Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With SARS-CoV-2 Infection
Lead sponsor
Evelo Biosciences, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
August 26, 2020
Completion date
May 19, 2021
Enrollment
16 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

covid19